Investment Rating - The industry investment rating is "Outperform the Market - A" [10] Core Insights - The retail pharmacy industry is experiencing a recovery in sales, with a 2.97% month-on-month increase in average daily sales per store in March 2025 [4][17] - The structure of listed pharmacy stores is gradually optimizing, which is expected to lead to stable performance growth for several companies [5][29] - The market size of domestic retail pharmacies decreased by 1.77% year-on-year in 2024, reaching 611.9 billion yuan [14] Summary by Sections Macro Perspective - In March 2025, the average daily sales per store in retail pharmacies showed a month-on-month increase, with average sales of 3,020.1 yuan [4][17] - The average daily sales for January to March 2025 were 2,973.8 yuan, 2,933.1 yuan, and 3,020.1 yuan respectively [17] Micro Perspective - The retail pharmacy industry has seen a slowdown in growth, but the concentration of the industry is expected to increase significantly. The market share of the top six listed pharmacies was only 16.89% in 2023 [23] - The revenue growth rates for the retail pharmacy industry and the top six listed pharmacies in 2023 were 1.83% and 11.83% respectively [23] - The proportion of new stores (2-3 years old) for major listed pharmacies in Q1-Q3 2024 was as follows: Yifeng Pharmacy 30%, Dazhenglin 25%, Laobaixing 30%, Yixintang 15%, Jianzhijia 38%, and Shuyupingmin 34% [5][29]

裘翔 ｜ 中信证券首席A股策略师 S1010518080002 策略聚焦 ｜ 再次高低切换 在彻底取消所有对华单边关税措施前，中美贸易谈判可能进展有限；国内的政策是托 底和应对式的，4月只是第一波以试验和预防为特征的政策；筹码出清相对彻底且对 业绩不敏感的主题阶段性占优；市场整体情绪位置不算低，科技板块相对医药和消费 更接近冰点，对风偏回升更敏感。配置上，5月关注新技术和产业题材轮动、海外科 技映射链修复以及服务业扩内需政策落地。 风险因素：中美科技、贸易、金融领域摩擦加剧；国内政策力度、实施效果或经济复 苏不及预期；海内外宏观流动性超预期收紧；俄乌、中东地区冲突进一步升级；我国 房地产库存消化不及预期；特朗普政策侧重点超预期。 杨帆｜中信证券 宏观与政策首席分析师 S1010515100001 中信证券｜强化底线思维，充分备足预案：政治局会议学习体会 2025年4月政治局会议指出，虽然一季度经济开局良好，但外部冲击影响加大，下行 风险显著上升；需要"强化底线思维"，对外部压力从最坏处准备，努力争取最好的结 果，因时而动用好政策工具箱，巩固经济与社会稳定。 风险因素：经济增速下行风险；政策力度或效果不及预期； ...

天眼查商业履历信息显示，中国国际金融股份有限公司成立于1995年7月，位于北京市，是一家以从事 其他金融业为主的企业。注册资本482725.6868万人民币，法定代表人为陈亮。 近期份额规模变动情况： 日期期间申购（亿份）期间赎回（亿份）期末总份额（亿份）期末净资产（亿元）净资产变动率2025- 03-310.000.000.020.02-2.54%2024-12-310.000.020.020.02-47.96%2024-09-300.000.020.040.04-27.77%2024- 06-300.290.350.060.06-49.10% 数据显示，该基金近3个月收益率0.55%，近一年收益率3.48%，成立以来收益率为-13.37%。其股票持 仓前十分别为：零跑汽车、分众传媒、中芯国际、腾讯控股、建设银行、招金矿业、北方华创、宁德时 代、神火股份、益丰药房，前十持仓占比合计8.59%。 截至2025年3月31日，中金公司旗下中金安心回报灵活配置混合C（920921）期末净资产0.68亿元，比上 期减少4.19%，该基金经理为顾柔刚。 简历显示，顾柔刚先生:国籍中国,管理学硕士。曾任中国农业银行信用卡 ...

Group 1 - The core point of the article highlights the performance and management of the CICC Select Stock A fund, which reported a net asset of 269 million yuan as of March 31, 2025, reflecting a 7.61% increase from the previous period [1][2] - The fund manager, Zhu Jiansheng, has a background in finance with experience at CICC and HSBC Jintrust Fund Management, indicating a strong expertise in stock research and investment [1][2] - Recent changes in the fund's share scale show a total share of 0.02 billion with a net asset change rate of -2.54% as of March 31, 2025, and a significant redemption activity in previous periods [2] Group 2 - The fund's recent performance metrics include a 5.33% return over the last three months and a 2.34% return over the past year, while the cumulative return since inception stands at -14.23% [2] - The top ten stock holdings of the fund account for a combined 35.52%, with notable companies such as Ningde Times and Yifeng Pharmacy among them [2] - CICC, established in July 1995, is primarily engaged in other financial services and has a registered capital of approximately 48.27 billion yuan [2]

Core Viewpoint - The company is utilizing idle raised funds for entrusted financial management to enhance fund efficiency and increase returns while ensuring that the original purpose of the raised funds remains unchanged [3][13]. Group 1: Entrusted Financial Management Details - The amount for entrusted financial management is 212 million yuan [4]. - The source of the funds is idle raised funds [5]. - The company has received approval from the China Securities Regulatory Commission for issuing convertible bonds totaling 1.797 billion yuan, with a net amount of approximately 1.780 billion yuan after deducting issuance costs [6]. Group 2: Approval and Procedures - The board of directors approved the proposal for using idle raised funds for entrusted financial management during the 15th meeting of the 5th board on April 15, 2025, allowing a maximum of 300 million yuan for this purpose [8]. - The investment products will be selected based on high safety and liquidity, with a validity period of 12 months for the approved amount [8]. Group 3: Risk Management and Control Measures - The company will conduct strict evaluations of investment products, focusing on low-risk financial products, while acknowledging potential market volatility risks [9][10]. - Measures include maintaining an investment ledger, regular audits by the audit department, and oversight by independent directors and supervisors [10][11]. Group 4: Impact on the Company - The investment in short-term financial products will not affect the normal operation of the company's main business or its daily cash flow needs [13]. - This strategy aims to generate additional investment returns, enhancing the company's performance and providing better returns for shareholders [13].

Group 1 - The core index of the China Securities Internet Medical Theme Index (CS Internet Medical, 930720) closed at 2534.82 points, with a trading volume of 4.515 billion yuan, reflecting a slight increase of 0.12% [1] - Over the past month, the CS Internet Medical Index has decreased by 5.58%, while it has increased by 14.02% over the past three months and by 7.06% year-to-date [1] - The index includes representative companies that provide hardware, software, or services for medical informationization and intelligence, with a base date of June 29, 2012, set at 1000.0 points [1] Group 2 - The top ten weighted companies in the CS Internet Medical Index are: Yifeng Pharmacy (6.75%), Daclin (6.71%), Laobaixing (6.14%), Wandong Medical (5.6%), Yixintang (5.58%), Jiuzhoutong (5.43%), Haier Biomedical (5.37%), Lepu Medical (5.32%), Yuyue Medical (5.18%), and Aier Eye Hospital (5.14%) [1] - The market share of the CS Internet Medical Index holdings is divided between Shenzhen Stock Exchange (50.91%) and Shanghai Stock Exchange (49.09%) [1] - In terms of industry composition, the holdings of the CS Internet Medical Index consist of 70.63% in pharmaceuticals and healthcare, 25.60% in information technology, and 3.77% in communication services [1] Group 3 - The index samples are adjusted quarterly, with adjustments implemented on the next trading day following the second Friday of March, June, September, and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with temporary adjustments made under special circumstances [2] - Companies that are delisted or undergo mergers, acquisitions, or splits are handled according to calculation and maintenance guidelines [2] Group 4 - Public funds tracking the CS Internet Medical Index include: Huatai-PineBridge China Securities Internet Medical A and Huatai-PineBridge China Securities Internet Medical C [3]

从指数持仓来看，中证全指医疗行业指数十大权重分别为：迈瑞医疗（14.15%）、爱尔眼科 （8.89%）、联影医疗（7.82%）、爱美客（4.05%）、惠泰医疗（4.0%）、鱼跃医疗（3.12%）、上海 医药（3.09%）、新产业（3.03%）、益丰药房（2.65%）、美年健康（2.5%）。 金融界4月22日消息，A股三大指数收盘涨跌不一，中证全指医疗行业指数 (医疗行业，932131)报537.08 点。 数据统计显示，中证全指医疗行业指数近一个月下跌5.24%，近三个月下跌0.28%，年至今下跌5.24%。 据了解，中证全指行业优选指数系列从中证全指行业中选取符合一定流动性与市值筛选条件的上市公司 作为指数样本，以反映各个行业内较具代表性与可投资性的上市公司证券的整体表现。该指数以2021年 12月31日为基日，以1000.0点为基点。 资料显示，指数样本每半年调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在下一个定期 调整日前，权重因子一般固定不变。遇临时调整时，当中证全指指数调整样本时，中证全指行业指数 ...

从中证500质量指数持仓的市场板块来看，上海证券交易所占比67.01%、深圳证券交易所占比32.99%。 从中证500质量指数持仓样本的行业来看，医药卫生占比29.63%、金融占比20.48%、信息技术占比 13.04%、可选消费占比12.50%、通信服务占比10.27%、工业占比6.64%、原材料占比4.85%、能源占比 1.96%、房地产占比0.64%。 资料显示，指数样本每半年度调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五的下 一交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在下一个定 期调整日前，权重因子一般固定不变。每次调整的样本数量一般不超过30%。特殊情况下将对指数进行 临时调整。当样本退市时，将其从指数样本中剔除。样本公司发生收购、合并、分拆等情形的处理，参 照计算与维护细则处理。 金融界4月21日消息，上证指数低开高走，中证500质量指数 (500质量，932432)报3134.91点。 数据统计显示，中证500质量指数近一个月下跌4.63%，近三个月上涨2.51%，年至今上涨2.95%。 据了解，中证500质量指数从中证500指数样本中选取 ...

国家统计局16日发布的数据显示，初步核算，一季度国内生产总值（GDP）318758亿元，按不变价格计算，同比增长5.4%，比上年四季度环比增长1.2%。 截至2025年4月17日 13:37，中证500质量成长指数(930939)下跌0.14%。成分股方面涨跌互现，中国汽研(601965)领涨5.83%，乖宝宠物(301498)上涨4.24%， 杰瑞股份(002353)上涨2.56%；益丰药房(603939)领跌3.06%，湖南黄金(002155)下跌3.06%，赤峰黄金(600988)下跌2.87%。500质量成长ETF(560500)上涨 0.22%，最新价报0.92元。（以上所列示股票为指数成份股，仅做示意不作为个股推荐。过往持仓情况不代表基金未来的投资方向，也不代表具体的投资建 议，投资方向、基金具体持仓可能发生变化。市场有风险，投资需谨慎。) Wind数据显示： 规模方面，500质量成长ETF近1周规模增长2172.20万元，实现显著增长，新增规模位居可比基金1/3。 份额方面，500质量成长ETF近1周份额增长1500.00万份，实现显著增长，新增份额位居可比基金1/3。 资金流入方面，500质量 ...

Summary of Conference Call Notes Industry Overview - The conference call focused on the consumer sector, particularly in the areas of healthcare, food and beverage, and retail, following the recent government policies aimed at stimulating consumption after the Two Sessions [1][2]. Key Points and Arguments Consumer Sector Insights - The consumer sector is experiencing a notable recovery, with significant growth observed in healthcare, beauty, and food and beverage sectors post-policy implementation [1]. - The overall strategy for the consumer sector is categorized into three directions: Strong, Change, and New [2][3]. Strong Segments - **Consumer Export**: Key players include Xiaogoods City, Miniso, and Anker Innovations, leveraging China's strong manufacturing supply chain for global branding [3][4]. - **Gold and Jewelry**: The sector is expected to benefit from rising gold prices, with companies like Lao Fengxiang and Chow Tai Fook identified as strong performers. The anticipated recovery in demand is expected to materialize by Q2 2025 [6][8]. Change Segments - Companies undergoing significant transformations, such as Shanghai Jahwa and Xiyu Tourism, are highlighted as potential investment opportunities [10][14]. - The beauty sector is also seen as having a significant opportunity for growth, particularly with the decline in advertising costs on platforms like Douyin [9][10]. New Consumption Trends - New consumption habits are emerging, with brands like Lao Pu Gold and Mi Xue Group being recognized for their innovative approaches and market positioning [11][12][13]. - The tea beverage market is highlighted, with Mi Xue Group being a standout performer due to its strong brand and profitability [13]. Healthcare Sector Insights - The healthcare segment, particularly in ophthalmology, is showing strong recovery, with companies like Purui Eye Hospital and Aier Eye Hospital expected to see revenue growth of 15-20% in Q1 [32][33][34]. - The overall trend in consumer healthcare is positive, with a notable increase in patient flow and service demand [33][36]. OTC and Pharmacy Recommendations - The OTC market, particularly in pediatric medicine, is expected to recover, with companies like Jianmin Group and Huate Dain being recommended for their growth potential [38][41][42]. - The pharmacy sector is also showing signs of recovery, with leading companies achieving positive growth despite previous challenges [38][39]. Additional Important Insights - The overall sentiment is optimistic regarding the consumer sector's recovery, with expectations of policy support and market improvements in the coming quarters [22][23]. - The conference emphasized the importance of identifying companies that have already shown signs of recovery and are positioned for growth as the market stabilizes [16][21][24]. Conclusion - The conference call provided a comprehensive overview of the consumer sector's current state and future potential, highlighting key companies and trends that investors should monitor for opportunities in the coming year [43].